| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |